Do you require a performance evaluation or performance study for your IVD? Would you like to apply and further develop your medical device under controlled conditions? We support your access to the European market.

LX CRO Services

Performance Evaluations

Do you require a performance evaluation or performance study for your IVD? Would you like to apply and further develop your medical device under controlled conditions?

We support your access to the European market.

Performance Studies & Evaluations

Reliable support from development through post-market activities

Regardless of your IVD’s risk class, our experienced multidisciplinary team of scientists, engineers and physicians will assess your specific situation. If you are preparing your IVD for CE marking, we identify the data required for your device, its intended use and its clinical performance in line with the intended purpose. Or do you require a post-market performance evaluation for an IVD that has already been successfully placed on the market?

In that case, we proactively collect and analyse the relevant data and prepare a report demonstrating the clinical performance and safety of your IVD. In accordance with Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR), you can draw on our expertise in scientific validity, analytical performance, clinical performance as well as safety.

Our services related to your IVD product take into account the requirements of Articles 56–77 of the IVDR and the ISO 20916 standard.

Services Included

In Vitro Diagnostic Medical Devices (IVDs)

What type of performance study does my product require – or is a clinical performance study required at all? Which stage of the clinical lifecycle has my product reached? How much clinical data needs to be generated?

This section helps you answer these and other key questions.

Tasks

Performance Evaluation Plan (PEP)

To plan, conduct and document the performance evaluation on an ongoing basis, the manufacturer must prepare a Performance Evaluation Plan (PEP). The PEP defines the performance evaluation process and its key parameters, taking into account the IVD’s intended purpose, the specification of the analyte or marker to be determined, the target populations, clearly defined indications, potential contraindications and limitations. The PEP should also describe the methodology and statistical approach used to assess and demonstrate analytical performance and, where applicable, clinical performance.

Performance Evaluation Plan (PEP)

To plan, conduct and document the performance evaluation on an ongoing basis, the manufacturer must prepare a Performance Evaluation Plan (PEP). The PEP defines the performance evaluation process and its key parameters, taking into account the IVD’s intended purpose, the specification of the analyte or marker to be determined, the target populations, clearly defined indications, potential contraindications and limitations. The PEP should also describe the methodology and statistical approach used to assess and demonstrate analytical performance and, where applicable, clinical performance.

State of the Art (SOTA)

The State of the Art (SOTA) describes current diagnostic options and generally accepted clinical practice relating to the disease or condition for which the IVD has been developed. A systematic literature review is essential because the SOTA plays a central role in several parts of the technical documentation. For example, Article 56 of the IVDR requires the clinical evidence, with reference to the SOTA, to scientifically demonstrate that the intended clinical benefit is achieved and that the device is safe. The SOTA must therefore be kept up to date throughout the product’s clinical lifecycle.

State of the Art (SOTA)

The State of the Art (SOTA) describes current diagnostic options and generally accepted clinical practice relating to the disease or condition for which the IVD has been developed. A systematic literature review is essential because the SOTA plays a central role in several parts of the technical documentation. For example, Article 56 of the IVDR requires the clinical evidence, with reference to the SOTA, to scientifically demonstrate that the intended clinical benefit is achieved and that the device is safe. The SOTA must therefore be kept up to date throughout the product’s clinical lifecycle.

Performance Evaluation Report (PER)

The Performance Evaluation Report (PER) brings together all elements of the clinical evidence and is therefore the central document for the performance evaluation of an IVD. Where applicable, the PER should include the scientific validity report, the analytical as well as clinical performance report, together with an evaluation of these reports to substantiate the clinical evidence. The PER must be updated throughout the device lifecycle – at least annually for Class C and D IVDs and as needed for Class A and B IVDs when new clinical data or post-market surveillance results become available, or when there are significant changes in the state of the art.

Performance Evaluation Report (PER)

The Performance Evaluation Report (PER) brings together all elements of the clinical evidence and is therefore the central document for the performance evaluation of an IVD. Where applicable, the PER should include the scientific validity report, the analytical as well as clinical performance report, together with an evaluation of these reports to substantiate the clinical evidence. The PER must be updated throughout the device lifecycle – at least annually for Class C and D IVDs and as needed for Class A and B IVDs when new clinical data or post-market surveillance results become available, or when there are significant changes in the state of the art.

Performance Studies

Performance studies must be conducted unless reliance on other sources of clinical performance data is duly justified. In accordance with Annex XIII of the IVDR, the justification must identify alternative sources that substantiate the clinical performance evaluation. Performance studies are intended to confirm aspects of an IVD’s performance that cannot be adequately demonstrated through analytical performance studies, literature reviews or routine diagnostic experience. For example, they may assess whether the IVD accurately measures the analyte in the intended target population.

Performance Studies

Performance studies must be conducted unless reliance on other sources of clinical performance data is duly justified. In accordance with Annex XIII of the IVDR, the justification must identify alternative sources that substantiate the clinical performance evaluation. Performance studies are intended to confirm aspects of an IVD’s performance that cannot be adequately demonstrated through analytical performance studies, literature reviews or routine diagnostic experience. For example, they may assess whether the IVD accurately measures the analyte in the intended target population.

Full-Service CRO

Your Advantage with LX CRO

Benefit from the combined expertise of our multidisciplinary medical writing team. As a full-service CRO specializing in medical devices and IVDs, we support both individual work packages as well as international, multicenter studies – from project management and design of the study through to the final Clinical Investigation Report.

Tailored Service Options

Let’s discuss your requirements and determine which option is right for you: One of our flexible modular services? Or one of our service packages? The choice is yours.

Transparent Cost Structure

Whether you choose modular services or our comprehensive end-to-end package, you will receive a detailed proposal with a clear and fully transparent cost breakdown.

Your ROI—Predictable and Secure

Our expertise helps you achieve your objectives faster, more efficiently and with greater cost control. We turn complex requirements into clear processes and targeted actions. This makes the return on your investment manageable.

IVD Enquiry

Dedicated expertise for your IVD study

Have you developed an innovative in vitro diagnostic medical device and are now preparing to bring it to market? We support you across the key processes!

We ensure that all interfaces and responsibilities are clearly defined and properly managed. With us, your projects stays aligned with current clinical and regulatory requirements.

Service Packages

Everything you need—from planning to regulatory approval

Rather than offering isolated services, our tailored packages provide an integrated solution from planning through to regulatory approval. Structured project management, clearly defined processes and evidence-based decision-making ensure efficiency, quality and regulatory compliance at every stage.

Tasks

Intro Package

The initial one-hour consultation is free of charge, giving us the opportunity to get to know you and understand your needs. You can then choose our flexible Intro Package, which gives you access to consulting support whenever required —without any long-term commitment.

As part of the Intro Package, we can also review individual documents, plan the next steps with you or provide practical guidance.

Because we are already familiar with your situation, we can respond quickly when an urgent need arises.

Intro Package

The initial one-hour consultation is free of charge, giving us the opportunity to get to know you and understand your needs. You can then choose our flexible Intro Package, which gives you access to consulting support whenever required —without any long-term commitment.

As part of the Intro Package, we can also review individual documents, plan the next steps with you or provide practical guidance.

Because we are already familiar with your situation, we can respond quickly when an urgent need arises.

Small Package

With our Small Package, you outsource selected tasks or documents to us. For example, we can take responsibility for specific elements of the clinical evaluation, such as the State Of The Art (SOTA) assessment or the literature search.

For a clinical investigation, the Small Package may include preparing the study synopsis, Clinical Investigation Plan or Statistical Analysis Plan. It can also cover individual study activities such as sample size calculation or EDC system setup.

Small Package

With our Small Package, you outsource selected tasks or documents to us. For example, we can take responsibility for specific elements of the clinical evaluation, such as the State Of The Art (SOTA) assessment or the literature search.

For a clinical investigation, the Small Package may include preparing the study synopsis, Clinical Investigation Plan or Statistical Analysis Plan. It can also cover individual study activities such as sample size calculation or EDC system setup.

Medium Package

With our Medium Package, we work alongside you as a project partner. We jointly carry out the project when you already have relevant in-house resources that require additional support or capacity. This package also applies when we take responsibility for a complete functional area, such as project management, medical writing, biostatistics, safety management, clinical monitoring or clinical data management. It provides a flexible way to add the resources you need on a modular basis.

The focus is on close collaboration as equal partners.

Medium Package

With our Medium Package, we work alongside you as a project partner. We jointly carry out the project when you already have relevant in-house resources that require additional support or capacity. This package also applies when we take responsibility for a complete functional area, such as project management, medical writing, biostatistics, safety management, clinical monitoring or clinical data management. It provides a flexible way to add the resources you need on a modular basis.

The focus is on close collaboration as equal partners.

Large Package

With our Large Package, we take full responsibility for your project as a comprehensive end-to-end service. You define the objectives; we manage the rest. The scope may include preparation of the Clinical Evaluation Report, the complete regulatory approval process, PMCF activities or an entire clinical study. Regular progress meetings keep you informed, while best-case, most-likely and worst-case timeline scenarios help you plan with greater confidence. You will always receive critical documents for review and approval, but can leave the overall project delivery to us.

Large Package

With our Large Package, we take full responsibility for your project as a comprehensive end-to-end service. You define the objectives; we manage the rest. The scope may include preparation of the Clinical Evaluation Report, the complete regulatory approval process, PMCF activities or an entire clinical study. Regular progress meetings keep you informed, while best-case, most-likely and worst-case timeline scenarios help you plan with greater confidence. You will always receive critical documents for review and approval, but can leave the overall project delivery to us.

We respond to project enquiries within 24 hours.